Jörg Kumbrink Selected Research

Monoclonal Antibodies

2/2023

Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jörg Kumbrink Research Topics

Disease

18	Neoplasms (Cancer) 03/2024 - 01/2020
8	Neoplasm Metastasis (Metastasis) 03/2024 - 08/2021
8	Colorectal Neoplasms (Colorectal Cancer) 02/2023 - 07/2018
3	Asthma (Bronchial Asthma) 03/2024 - 12/2019
3	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2021
2	Peritoneal Neoplasms 03/2024 - 11/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2024 - 09/2022
2	Breast Neoplasms (Breast Cancer) 08/2021 - 12/2020
1	Brain Neoplasms (Brain Tumor) 03/2024
1	Vulvar Neoplasms (Vulvar Cancer) 02/2024
1	Carcinoma (Carcinomatosis) 01/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Carcinogenesis 01/2023
1	Margins of Excision 09/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022
1	Inflammation (Inflammations) 12/2020
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 12/2020
1	Heart Failure 01/2019
1	Acne Vulgaris 07/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2018

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 03/2024 - 07/2018
6	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 07/2018
3	Messenger RNA (mRNA)IBA 03/2024 - 01/2019
3	Formaldehyde (Formol)FDA Link 01/2024 - 01/2020
3	ParaffinIBA 01/2024 - 01/2020
2	Cetuximab (Erbitux)FDA Link 02/2023 - 01/2021
2	Cell-Free Nucleic AcidsIBA 09/2022 - 01/2020
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 11/2021
2	Hormones (Hormone)IBA 08/2021 - 12/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 07/2018
2	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2020
1	Interferon-alpha (Interferon Alfa)IBA 01/2024
1	Monoclonal AntibodiesIBA 02/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	Differentiation AntigensIBA 01/2023
1	olfactomedinIBA 01/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	PlatinumIBA 07/2022
1	durvalumabIBA 07/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Aurora Kinase AIBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 11/2021
1	Leucovorin (Folinic Acid)FDA Link 11/2021
1	Crk-Associated Substrate ProteinIBA 11/2021
1	Bevacizumab (Avastin)FDA Link 11/2021
1	human ERBB2 proteinIBA 08/2021
1	AntibodiesIBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2020
1	Estrogen ReceptorsIBA 12/2020
1	Aromatase InhibitorsIBA 12/2020
1	Tamoxifen FDA LinkGeneric 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2019
1	Immunoglobulin FragmentsIBA 07/2018

Therapy/Procedure

9	Therapeutics 03/2024 - 12/2020
3	Precision Medicine 02/2024 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2023 - 07/2022
1	Genomic Medicine 01/2024
1	Investigational Therapies (Experimental Therapy) 05/2023
1	Aftercare (After-Treatment) 07/2022
1	Chemoradiotherapy 07/2022
1	Combined Modality Therapy 07/2022
1	Transplantation 11/2021